MiNK Therapeutics, Inc.INKTNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank80
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
39.38%
↑ 26678% vs avg
Percentile
P80
Within normal range
Streak
3 yr
Consecutive growthAccelerating
Average
-0.15%
Historical baseline
PeriodValue
202439.38%
202316.45%
2022-47.09%
2021-53.84%
202044.21%
20190.00%